Brinker International’s policy on antibiotics lacks detail, and the company has not responded to investor concerns on their antibiotics policy and use within its supply chain.
The company owns or franchises around 1,600 restaurants across its two brands, and its menus are primarily meat based. The company continues to lag behind their US peers, including in the casual dining sector, with several chains committing to eliminate medically important antibiotics from their meat and dairy supply chains. The company has also been subject to a shareholder resolution focused on adopting an enterprise-wide policy to phase out the routine use of medically important antibiotics for disease prevention purposes in its meat and poultry supply chain. However, this was withdrawn in 2018 on the premise that Brinker will soon announce an updated policy. This has yet to materialise.
We would encourage Brinker International to:
- Extend their policy to cover all relevant animal-derived proteins where antibiotics are prevalent.
- Extend their policy to cover all relevant markets in which it operates in.
- Extending the scope of their policy to phase out the routine use of all antibiotics and/ or only use antibiotics when there is a disease present and administered by a veterinarian.
- Commit to third-party audits across all relevant markets and species to ensure compliance.
- Report more comprehensively and publicly on implementation progress including antibiotics use.
No information provided